Skip to search formSkip to main contentSkip to account menu

ABI007

Known as: ABI 007, ABI-007 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

130-nm albumin-bound paclitaxelpaclitaxel protein-bound

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
A phase II trial of neoadjuvant ABI-007, carboplatin, and gemcitabine (ACG) in patients with locally advanced carcinoma of the bladder.
244 Background: Neoadjuvant cisplatin-based chemotherapy benefits patients with bladder cancer, particularly in the 30% with… 
2011
2011
Results of a phase II study of single-agent nab-paclitaxel in platinum-refractory second-line metastatic urothelial carcinoma (UC).
241 Background: There is currently no standard second-line chemotherapy for platinum- refractory UC. Both paclitaxel and… 
Review
2008
Review
2008
Epithelioid angiosarcoma of the uterus: a review of management
BackgroundUterine epithelioid angiosarcoma is extremely rare. Evidence-based advice regarding optimal management is lacking… 
Highly Cited
2006
Highly Cited
2006
Influence of Formulation Vehicle on Metronomic Taxane Chemotherapy: Albumin-Bound versus Cremophor EL–Based Paclitaxel
Purpose: Low-dose metronomic chemotherapy treatments, especially when combined with ‘dedicated’ antiangiogenic agents, can induce… 
2006
2006
Albumin-Bound Paclitaxel, ABI-007 May Show Better Efficacy than Paclitaxel in Basal-Like Breast Cancers: Association Between Caveolin-1 Expression and ABI-007
2006
2006
SPARC expression in head and neck cancer correlates with tumor response to nanoparticle albumin-bound paclitaxel (nab-paclitaxel, ABI-007, Abraxane)
Proc Amer Assoc Cancer Res, Volume 47, 2006 4477 Background: SPARC, a matricellular protein upregulated in aggressive cancers… 
Review
2006
Review
2006
Dose escalation study of nab-paclitaxel followed by carboplatin as first line therapy in advanced non-small cell lung cancer (NSCLC).
7132 Background: Paclitaxel for injection formulated in Cremophor® and ethanol (Taxol®, Cremophor paclitaxel) 225 mg/m2 and… 
2005
2005
North Central Cancer Treatment Group N0531: Phase II Trial of weekly albumin-bound paclitaxel (ABI-007; Abraxane) in combination with gemcitabine in patients with metastatic breast cancer.
2005
2005
Open-label, multicenter, phase II trial of ABI-007 in previously treated and previously untreated patients with metastatic malignant melanoma
7558 Background: ABI-007 (Abraxane TM), is an albumin-bound, nanoparticle form of paclitaxel with an improved therapeutic index… 
2004
2004
601 Increased transport of nanoparticle albumin-bound paclitaxel (ABI-007) by endothelial gp60-mediated caveolar transcytosis: a pathway inhibited by Taxol
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)